Neiepirkto parenterāli ievadāmo zāļu iegāde onkoloģisko saslimšanu ārstēšanai 2019. gadam
Nacionālais veselības dienests
Published and bidding deadline .
Integrity Indicators
1 out of 3- No disputes from bidders or outsiders
- Sellers have recently made political party donations
- Bidding period is associated with an increased risk factor
Estimated Cost
Actual Cost
Duration
31 daysBidders
0 biddersBids
0 bidsDisputes
0 disputesNeiepirkto parenterāli ievadāmo zāļu iegāde onkoloģisko saslimšanu ārstēšanai 2019. gadā.
Process Type | Open procedure |
---|---|
Offers Revealed At |
Contracts
Sabiedrība ar ierobežotu atbildību "MAGNUM MEDICAL"award-1. Cytarabinum 100 mg/ml – 50 ml Signed . | €18,028.76 | |||||||||||||||
AS "RECIPE PLUS"award-2. Cytarabinum 100 mg/ ml — 1 ml Signed . | €18,028.76 | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
Sabiedrība ar ierobežotu atbildību "Tamro"award-3. Cytarabinum 100 mg/ ml — 1 ml Signed . | €18,028.76 |